chr18-62045940-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_176787.5(PIGN):​c.2712T>G​(p.Phe904Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,613,384 control chromosomes in the GnomAD database, including 151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F904C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0083 ( 6 hom., cov: 32)
Exomes 𝑓: 0.012 ( 145 hom. )

Consequence

PIGN
NM_176787.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.753
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005876571).
BP6
Variant 18-62045940-A-C is Benign according to our data. Variant chr18-62045940-A-C is described in ClinVar as [Benign]. Clinvar id is 472226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-62045940-A-C is described in Lovd as [Benign]. Variant chr18-62045940-A-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00831 (1266/152310) while in subpopulation NFE AF = 0.0144 (980/68020). AF 95% confidence interval is 0.0137. There are 6 homozygotes in GnomAd4. There are 553 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.2712T>G p.Phe904Leu missense_variant Exon 31 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.2712T>G p.Phe904Leu missense_variant Exon 31 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.2712T>G p.Phe904Leu missense_variant Exon 30 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.*680T>G non_coding_transcript_exon_variant Exon 29 of 29 5 ENSP00000491963.1 A0A1W2PQZ1
PIGNENST00000638424.1 linkn.*680T>G 3_prime_UTR_variant Exon 29 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.00832
AC:
1266
AN:
152192
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00663
Gnomad FIN
AF:
0.00320
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0144
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00937
AC:
2327
AN:
248306
AF XY:
0.00976
show subpopulations
Gnomad AFR exome
AF:
0.00208
Gnomad AMR exome
AF:
0.00433
Gnomad ASJ exome
AF:
0.00478
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00553
Gnomad NFE exome
AF:
0.0149
Gnomad OTH exome
AF:
0.00861
GnomAD4 exome
AF:
0.0122
AC:
17805
AN:
1461074
Hom.:
145
Cov.:
30
AF XY:
0.0120
AC XY:
8710
AN XY:
726762
show subpopulations
Gnomad4 AFR exome
AF:
0.00185
AC:
62
AN:
33472
Gnomad4 AMR exome
AF:
0.00459
AC:
205
AN:
44656
Gnomad4 ASJ exome
AF:
0.00479
AC:
125
AN:
26120
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39696
Gnomad4 SAS exome
AF:
0.00791
AC:
681
AN:
86110
Gnomad4 FIN exome
AF:
0.00562
AC:
300
AN:
53388
Gnomad4 NFE exome
AF:
0.0142
AC:
15818
AN:
1111514
Gnomad4 Remaining exome
AF:
0.00935
AC:
564
AN:
60350
Heterozygous variant carriers
0
789
1579
2368
3158
3947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00831
AC:
1266
AN:
152310
Hom.:
6
Cov.:
32
AF XY:
0.00743
AC XY:
553
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.00255
AC:
0.00254992
AN:
0.00254992
Gnomad4 AMR
AF:
0.00373
AC:
0.003725
AN:
0.003725
Gnomad4 ASJ
AF:
0.00432
AC:
0.00432028
AN:
0.00432028
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00663
AC:
0.00663075
AN:
0.00663075
Gnomad4 FIN
AF:
0.00320
AC:
0.0032003
AN:
0.0032003
Gnomad4 NFE
AF:
0.0144
AC:
0.0144075
AN:
0.0144075
Gnomad4 OTH
AF:
0.00710
AC:
0.00710227
AN:
0.00710227
Heterozygous variant carriers
0
62
124
186
248
310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
31
Bravo
AF:
0.00822
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0122
AC:
47
ESP6500AA
AF:
0.00222
AC:
9
ESP6500EA
AF:
0.0127
AC:
107
ExAC
AF:
0.00995
AC:
1203
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Apr 16, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGN: BP4, BS1, BS2 -

not specified Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 17, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.3
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;.;T;T;T;.;.;.;.;.;T;.;.;T;.;T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.82
.;.;.;.;.;.;T;.;T;T;.;T;T;.;T;T
MetaRNN
Benign
0.0059
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.2
M;.;M;M;M;.;.;.;.;.;M;.;.;M;.;M
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-4.0
.;.;.;D;.;.;.;.;.;.;D;.;.;.;.;.
REVEL
Benign
0.093
Sift
Benign
0.097
.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.
Sift4G
Benign
0.28
.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.
Polyphen
0.024
B;.;B;B;B;.;.;.;.;.;B;.;.;B;.;B
Vest4
0.27, 0.33
MutPred
0.15
Loss of MoRF binding (P = 0.4134);.;Loss of MoRF binding (P = 0.4134);Loss of MoRF binding (P = 0.4134);Loss of MoRF binding (P = 0.4134);.;.;.;.;.;Loss of MoRF binding (P = 0.4134);.;.;Loss of MoRF binding (P = 0.4134);.;Loss of MoRF binding (P = 0.4134);
MVP
0.31
MPC
0.026
ClinPred
0.036
T
GERP RS
0.22
Varity_R
0.21
gMVP
0.25
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34231046; hg19: chr18-59713173; API